- Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
- We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally.
- We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.
Latest News
-
2021-12-30Genor Biopharma included on the "2021 New Economy Most Valuable Listed Company" list by CaiLian Press
-
2021-12-28Genor Biopharma announces the appointment of several world-renowned experts to its Scientific Advisory Board
-
2021-12-22Genor Biopharma announces submission of clinical trial application for EGFR/cMET/cMET trispecific antibody (GB263T) in Australia
Find Out More
